Literature DB >> 16832305

Diabetic retinopathy: the latest in current management.

Abdhish R Bhavsar1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16832305     DOI： 10.1097/01.iae.0000236466.23640.c9

Source DB:  PubMed          Journal:  Retina        ISSN： 0275-004X            Impact factor:   4.256


× No keyword cloud information.
  18 in total

Review 1.  A review of therapies for diabetic macular oedema and rationale for combination therapy.

Authors:  W M K Amoaku; S Saker; E A Stewart
Journal:  Eye (Lond)       Date:  2015-06-26       Impact factor: 3.775

2.  Diabetic retinopathy.

Authors:  Fadia T Shaya; Mohammad Aljawadi
Journal:  Clin Ophthalmol       Date:  2007-09

3.  Effects of anti-VEGF agents on rat retinal Müller glial cells.

Authors:  Bin Guo; Yingli Wang; Yannian Hui; Xinguang Yang; Qinhua Fan
Journal:  Mol Vis       Date:  2010-05-01       Impact factor: 2.367

4.  Pharmacologic therapies for diabetic retinopathy and diabetic macular edema.

Authors:  Ehud Rechtman; Alon Harris; Hanna J Garzozi; Thomas A Ciulla
Journal:  Clin Ophthalmol       Date:  2007-12

Review 5.  Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases.

Authors:  Ramya Krishna Vadlapatla; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Curr Drug Targets       Date:  2013-07       Impact factor: 3.465

6.  The rs3917779 polymorphism of P-selectin's significant association with proliferative diabetic retinopathy in Yazd, Iran.

Authors:  Parisa Kolahdouz; Ehsan Farashahi Yazd; Masoud Tajamolian; Masoud Reza Manaviat; Mohammad Hasan Sheikhha
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-07       Impact factor: 3.117

Review 7.  Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group.

Authors:  Winfried M Amoaku; Faruque Ghanchi; Clare Bailey; Sanjiv Banerjee; Somnath Banerjee; Louise Downey; Richard Gale; Robin Hamilton; Kamlesh Khunti; Esther Posner; Fahd Quhill; Stephen Robinson; Roopa Setty; Dawn Sim; Deepali Varma; Hemal Mehta
Journal:  Eye (Lond)       Date:  2020-06       Impact factor: 3.775

8.  BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cells.

Authors:  Jin-Zhong Zhang; Megan E Cavet; Karl R VanderMeid; Mercedes Salvador-Silva; Francisco J López; Keith W Ward
Journal:  Mol Vis       Date:  2009-12-08       Impact factor: 2.367

9.  Calcium dobesilate reduces endothelin-1 and high-sensitivity C-reactive protein serum levels in patients with diabetic retinopathy.

Authors:  Alireza Javadzadeh; Amir Ghorbanihaghjo; Farzad Hami Adl; Dima Andalib; Hassan Khojasteh-Jafari; Kamyar Ghabili
Journal:  Mol Vis       Date:  2013-01-10       Impact factor: 2.367

10.  Role of N-ε- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus.

Authors:  Subhadip Choudhuri; Deep Dutta; Aditi Sen; Imran Hussain Chowdhury; Bhaskar Mitra; Lakshmi Kanta Mondal; Avijit Saha; Gautam Bhadhuri; Basudev Bhattacharya
Journal:  Mol Vis       Date:  2013-01-28       Impact factor: 2.367
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.